Related Experiment Video
Updated: Jul 14, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Presence of Epstein-Barr virus in cerebrospinal fluid is associated with increased mortality in HIV-negative
Yi Lu1,2, Shubo Li3, Zhihui Su1
1Department of Neurology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, PR China.
Abstract:
Cryptococcus neoformans is the most common cause of fungal meningitis and is associated with a high mortality. The clinical significance of concurrent Epstein-Barr virus (EBV) in the cerebrospinal fluid (CSF) of human immunodeficiency virus (HIV)-negative patients with cryptococcal meningitis (CM) remains unclear. A retrospective cohort study was performed by analyzing CSF samples from 79 HIV-negative Chinese Han patients with confirmed CM. We identified CSF viral DNA in these patients by metagenomic next-generation sequencing (mNGS) and compared 10-week survival rates among those with and without EBV DNA in CSF. Of the 79 CSF samples tested, 44.3% (35/79) had detectable viral DNA in CSF, while 55.7% (44/79) were virus-negative. The most frequent viral pathogen was EBV, which was detected in 22.8% (18/79) patients. The median number of CSF-EBV DNA reads was 4 reads with a range from 1 to 149 reads. The 10-week mortality rates were 22.2% (4/18) in those with positive CSF-EBV and 2.3% (1/44) in those with negative CSF-virus (hazard ratio 8.20, 95% confidence interval [CI] 1.52-81.80; P = 0.014), which remained significant after a multivariate adjustment for the known risk factors of mortality (adjusted hazard ratio 8.15, 95% CI 1.14-92.87; P = 0.037). mNGS can identify viruses that coexist in CSF of HIV-negative patients with CM. EBV DNA is most commonly found together with C. neoformans in CSF and its presence is associated with increased mortality in HIV-negative CM patients.
Insights
Epstein-Barr virus (EBV) DNA in cerebrospinal fluid (CSF) is common in HIV-negative patients with cryptococcal meningitis (CM). Its presence significantly increases the risk of mortality within 10 weeks.
Area of Science:
- Infectious Diseases
- Virology
- Neuroscience
Background:
- Cryptococcus neoformans causes fungal meningitis with high mortality.
- The role of concurrent Epstein-Barr virus (EBV) in HIV-negative patients with cryptococcal meningitis (CM) is not well understood.
Purpose of the Study:
- To investigate the prevalence of viral DNA in CSF of HIV-negative CM patients.
- To determine the association between Epstein-Barr virus (EBV) DNA and mortality in this patient group.
Main Methods:
- Retrospective cohort study of 79 HIV-negative Chinese Han patients with CM.
- Metagenomic next-generation sequencing (mNGS) used to detect viral DNA in CSF samples.
- Comparison of 10-week survival rates between patients with and without CSF EBV DNA.
Main Results:
- Viral DNA was detected in 44.3% of CSF samples; EBV was the most frequent virus (22.8%).
- Patients with EBV DNA in CSF had a significantly higher 10-week mortality rate (22.2% vs. 2.3%).
- This association remained significant after multivariate adjustment for known mortality risk factors.
Conclusions:
- Metagenomic next-generation sequencing (mNGS) effectively identifies co-infecting viruses in CSF.
- Epstein-Barr virus (EBV) DNA in CSF is associated with increased mortality in HIV-negative patients with cryptococcal meningitis (CM).
Related Concept Videos
Viral Meningitis
Cytomegalovirus Disease
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Encephalitis l: Introduction
Cerebral Edema ll: Pathophysiology

